Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Wilkins

Showing results (11-20 of 896) with videos related to

Pageof 90
Sort By:
Pulmonary Circulation|May 11, 2013
Developing treatments for pulmonary arterial hypertensionMartin R Wilkins
American Journal of Respiratory and Critical Care Medicine|September 21, 2017
Apoptosis Signal-Regulating Kinase 1 Inhibition in Pulmonary Hypertension. Too Much to ASK?Martin R Wilkins
Clinical Medicine (London, England)|March 9, 2006
Cannabis and cannabis-based medicines: potential benefits and risks to healthMartin R Wilkins,
Biochemical Society Transactions|August 1, 1993
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular diseaseM R Wilkins
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2012
Pulmonary hypertension: the science behind the disease spectrumM R Wilkins
Radiology. Imaging Cancer|March 29, 2021
Combination of Chemoembolization plus Radiofrequency Ablation May Provide Better Survival Outcomes than Monotherapy for HCCLuke R Wilkins
American Journal of Respiratory and Critical Care Medicine|February 10, 2004
Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertensionMartin R Wilkins
Electrophoresis|May 15, 2009
Hares and tortoises: the high- versus low-throughput proteomic raceMarc R Wilkins
The British Journal of Ophthalmology|January 26, 2012
Reporting outcomes of randomised controlled trialsMark R Wilkins
Pulmonary Circulation|July 10, 2014
Pulmonary hypertension: the value of experimental medicine in new drug developmentMartin R Wilkins
Pageof 90

Showing results (11-20 of 896) with videos related to

Sort By:
Pageof 90
Pulmonary Circulation|May 11, 2013
Developing treatments for pulmonary arterial hypertensionMartin R Wilkins
American Journal of Respiratory and Critical Care Medicine|September 21, 2017
Apoptosis Signal-Regulating Kinase 1 Inhibition in Pulmonary Hypertension. Too Much to ASK?Martin R Wilkins
Clinical Medicine (London, England)|March 9, 2006
Cannabis and cannabis-based medicines: potential benefits and risks to healthMartin R Wilkins,
Biochemical Society Transactions|August 1, 1993
Clinical potential of endopeptidase-24.11 inhibitors in cardiovascular diseaseM R Wilkins
European Respiratory Review : an Official Journal of the European Respiratory Society|March 2, 2012
Pulmonary hypertension: the science behind the disease spectrumM R Wilkins
Radiology. Imaging Cancer|March 29, 2021
Combination of Chemoembolization plus Radiofrequency Ablation May Provide Better Survival Outcomes than Monotherapy for HCCLuke R Wilkins
American Journal of Respiratory and Critical Care Medicine|February 10, 2004
Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertensionMartin R Wilkins
Electrophoresis|May 15, 2009
Hares and tortoises: the high- versus low-throughput proteomic raceMarc R Wilkins
The British Journal of Ophthalmology|January 26, 2012
Reporting outcomes of randomised controlled trialsMark R Wilkins
Pulmonary Circulation|July 10, 2014
Pulmonary hypertension: the value of experimental medicine in new drug developmentMartin R Wilkins
Pageof 90